<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:chebi fb="0" ids="39027">Very low density lipoprotein</z:chebi> (<z:chebi fb="1" ids="39027">VLDL</z:chebi>) particles are <z:hpo ids='HP_0001425'>heterogeneous</z:hpo>, comprising two main subspecies, <z:chebi fb="1" ids="39027">VLDL</z:chebi> 1 (Sf 60-400) and <z:chebi fb="1" ids="39027">VLDL</z:chebi> 2 (Sf 20-60) </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the study was to examine the distribution and composition of <z:chebi fb="1" ids="39027">VLDL</z:chebi> subspecies in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>SUBJECTS, MATERIALS AND METHODS: We studied the composition and concentration of <z:chebi fb="0" ids="17855">triglyceride</z:chebi>-rich <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> (TRLs) in 217 type 2 diabetic patients and 93 control subjects between 50 and 75 years of age </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="1" ids="6495">Lipoprotein</z:chebi> subspecies were separated by density-gradient ultracentrifugation </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="39015">Apolipoprotein</z:chebi> (apo) CIII and apo E in plasma and apo CIII in TRL subspecies were measured by nephelometry and apo CII in serum by a commercial kit using a single radial immunodiffusion method </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The concentrations of <z:chebi fb="1" ids="39027">VLDL</z:chebi> 1, <z:chebi fb="1" ids="39027">VLDL</z:chebi> 2 and intermediate density <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> were significantly increased in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> subjects, the change being most marked for <z:chebi fb="1" ids="39027">VLDL</z:chebi> 1 </plain></SENT>
<SENT sid="6" pm="."><plain>There was a strong linear correlation between <z:chebi fb="1" ids="39027">VLDL</z:chebi> 1 triglycerides and plasma <z:chebi fb="4" ids="17855">triglycerides</z:chebi> in both groups (r = 0.879, p &lt; 0.001 and r = 0.899, p &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Diabetic subjects had markedly higher plasma ratios of apo CII:apo CIII and apo CIII:apo E </plain></SENT>
<SENT sid="8" pm="."><plain>Despite elevated plasma apo CIII, type 2 diabetic subjects had a relative deficiency of apo CIII in <z:hpo ids='HP_0000001'>all</z:hpo> TRL subspecies, suggesting profound disturbances of apo CIII metabolism </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: The elevation of <z:chebi fb="1" ids="39027">VLDL</z:chebi> 1 triglycerides is the major determinant of plasma <z:chebi fb="0" ids="17855">triglyceride</z:chebi> concentration in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects and in type 2 diabetic individuals </plain></SENT>
<SENT sid="10" pm="."><plain>Both apo CIII and apo E metabolism are disturbed in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>